Within 24.51m of 486.30 g/t AgEq Silver47 Exploration Corp. (TSXV: AGA) (‘Silver47’ or the ‘Company), is pleased to announce the first results from the 2024 drill program at the Company’s…
Latest News
-
-
/NOT FOR DISTRIBUTION TO UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ TSX Venture Exchange (TSX-V): LIT Frankfurt Stock Exchange (FSE): OAY3 OTCQX Venture Market: LILIF Argentina Lithium & Energy Corp.…
-
HIGHLIGHTS 27m @ 2.7 grams per tonne (‘g/t’) gold equivalent (AuEq.), including 12m @ 3.9 g/t AuEq. from 435m downhole in OEDD-98. 10m @ 2.8 g/t AuEq. within 22m @…
-
Group Eleven Resources Corp. (TSXV: ZNG) (OTC Pink: GRLVF) is pleased to announce its participation at the upcoming New Orleans Investment Conference on Saturday, November 23rd at the Hilton New…
-
Attorneys for X Corp., the firm established by Elon Musk to take over Twitter, filed a notice of appearance on Thursday in the bankruptcy case of Alex Jones and his…
-
Investing
Gunnison Releases PEA for Arizona Copper Project, Plans for Open-pit, Heap-leach Operation
Gunnison Copper (TSX:GCU,OTCQB:EXMGF) is shifting its development strategy for the Gunnison copper project in Arizona, US, laying out plans for a conventional open-pit and heap-leach operation. In a preliminary economic…
-
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release This post appeared first on investingnews.com
-
Investing
Spodumene Pegmatite Discovery at Esperança Project in Brazil Yields LIBS Results up to 4.04% Li2O
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired Esperança project. The discovery supports the…
-
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress on its ISLA-101 Phase 2a/b clinical trial in dengue fever. All…
-
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the company’s achievements while waiting for the…